Published in Proc Natl Acad Sci U S A on September 13, 1994
The papillomavirus E1 protein forms a DNA-dependent hexameric complex with ATPase and DNA helicase activities. J Virol (1998) 1.77
The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex. Proc Natl Acad Sci U S A (1994) 1.64
Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J Virol (1997) 1.61
Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J Virol (1999) 1.56
Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex. EMBO J (2002) 1.45
Characterization of the DNA-binding domain of the bovine papillomavirus replication initiator E1. J Virol (1998) 1.45
Parvovirus initiator protein NS1 and RPA coordinate replication fork progression in a reconstituted DNA replication system. J Virol (2002) 1.43
Functional interactions between papillomavirus E1 and E2 proteins. J Virol (1997) 1.42
Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor. EMBO J (1998) 1.37
Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J Virol (1995) 1.31
Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin. J Virol (2000) 1.22
The initiator protein E1 binds to the bovine papillomavirus origin of replication as a trimeric ring-like structure. EMBO J (1996) 1.20
E1 initiator DNA binding specificity is unmasked by selective inhibition of non-specific DNA binding. EMBO J (2003) 1.14
The E1 initiator recognizes multiple overlapping sites in the papillomavirus origin of DNA replication. J Virol (2001) 1.13
E1 recognition sequences in the bovine papillomavirus type 1 origin of DNA replication: interaction between half sites of the inverted repeats. J Virol (1995) 1.11
Isolation of an amino-terminal region of bovine papillomavirus type 1 E1 protein that retains origin binding and E2 interaction capacity. J Virol (1997) 1.11
Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions. J Virol (1997) 1.08
The E1 proteins. Virology (2013) 1.02
Sequential and ordered assembly of E1 initiator complexes on the papillomavirus origin of DNA replication generates progressive structural changes related to melting. Mol Cell Biol (2002) 0.99
Common determinants in DNA melting and helicase-catalysed DNA unwinding by papillomavirus replication protein E1. Nucleic Acids Res (2006) 0.98
Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication. J Virol (1999) 0.97
ATP-dependent minor groove recognition of TA base pairs is required for template melting by the E1 initiator protein. J Virol (2007) 0.93
Identification of a short, hydrophilic amino acid sequence critical for origin recognition by the bovine papillomavirus E1 protein. J Virol (2000) 0.92
Role of ATP hydrolysis in the DNA translocase activity of the bovine papillomavirus (BPV-1) E1 helicase. Nucleic Acids Res (2006) 0.91
AP1 enhances polyomavirus DNA replication by promoting T-antigen-mediated unwinding of DNA. J Virol (1996) 0.91
Bending of adenovirus origin DNA by nuclear factor I as shown by scanning force microscopy is required for optimal DNA replication. J Virol (2004) 0.89
Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J Mol Biol (2007) 0.85
A fifteen-amino-acid peptide inhibits human papillomavirus E1-E2 interaction and human papillomavirus DNA replication in vitro. J Virol (1998) 0.83
A multifunctional plasmid-encoded replication initiation protein both recruits and positions an active helicase at the replication origin. Proc Natl Acad Sci U S A (2003) 0.83
Murine polyomavirus and simian virus 40 large T antigens produce different structural alterations in viral origin DNA. J Virol (1995) 0.83
Role of papillomavirus E1 initiator dimerization in DNA replication. J Virol (2005) 0.83
A DNA-binding activity in BPV initiator protein E1 required for melting duplex ori DNA but not processive helicase activity initiated on partially single-stranded DNA. Nucleic Acids Res (2008) 0.81
Surface mutagenesis of the bovine papillomavirus E1 DNA binding domain reveals residues required for multiple functions related to DNA replication. J Virol (2006) 0.81
CK2 phosphorylation inactivates DNA binding by the papillomavirus E1 and E2 proteins. J Virol (2013) 0.78
Distinct roles of two binding sites for the bovine papillomavirus (BPV) E2 transactivator on BPV DNA replication. J Virol (1998) 0.75
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci U S A (1981) 9.27
Duplex opening by dnaA protein at novel sequences in initiation of replication at the origin of the E. coli chromosome. Cell (1988) 6.42
Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J (1991) 6.00
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
Binding and unwinding--how T antigen engages the SV40 origin of DNA replication. Cell (1990) 4.65
Activation of BPV-1 replication in vitro by the transcription factor E2. Nature (1991) 4.51
Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J (1991) 3.98
Localized melting and structural changes in the SV40 origin of replication induced by T-antigen. EMBO J (1988) 3.96
DNA supercoiling promotes formation of a bent repression loop in lac DNA. J Mol Biol (1987) 3.81
The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication. Cell (1993) 3.68
The papillomavirus E2 regulatory proteins. J Biol Chem (1991) 3.27
The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci U S A (1993) 3.26
Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc Natl Acad Sci U S A (1993) 2.95
Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc Natl Acad Sci U S A (1993) 2.74
The DNA unwinding element: a novel, cis-acting component that facilitates opening of the Escherichia coli replication origin. EMBO J (1989) 2.61
Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1. Proc Natl Acad Sci U S A (1991) 2.53
The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc Natl Acad Sci U S A (1993) 2.35
Initiation protein induced helix destabilization at the lambda origin: a prepriming step in DNA replication. Cell (1988) 2.24
Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle. Cell (1987) 2.22
Binding of bovine papillomavirus E1 to the origin is not sufficient for DNA replication. Virology (1993) 1.79
DNA binding specificity of the bovine papillomavirus E1 protein is determined by sequences contained within an 18-base-pair inverted repeat element at the origin of replication. J Virol (1994) 1.51
Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site. J Biol Chem (1993) 1.39
EBNA1 distorts oriP, the Epstein-Barr virus latent replication origin. J Virol (1992) 1.34
Strand and face: the topography of interactions between the SV40 origin of replication and T-antigen during the initiation of replication. EMBO J (1994) 1.28
Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines. J Virol (1992) 1.14
Inhibition of structural changes in the simian virus 40 core origin of replication by mutation of essential origin sequences. J Virol (1992) 1.09
Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature (1981) 13.89
Characterization of the bovine papilloma virus plasmid maintenance sequences. Cell (1984) 5.01
Genetic analysis of bovine papillomavirus type 1 trans-acting replication factors. J Virol (1985) 4.74
Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Mol Cell Biol (1983) 4.56
Replication of simian virus 40 origin-containing DNA in vitro with purified proteins. Proc Natl Acad Sci U S A (1987) 3.97
Replication protein A (RPA): the eukaryotic SSB. Crit Rev Biochem Mol Biol (1999) 3.85
Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc Natl Acad Sci U S A (1993) 2.95
Bovine papilloma virus (BPV)-encoded E2 protein enhances binding of E1 protein to the BPV replication origin. Proc Natl Acad Sci U S A (1993) 2.74
Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor. Cell (1986) 2.58
Transient replication of bovine papilloma virus type 1 plasmids: cis and trans requirements. Proc Natl Acad Sci U S A (1986) 2.49
Effect of repetitive imaging on topographic measurements of the optic nerve head. Arch Ophthalmol (1993) 2.40
Expression of two proteins from overlapping and oppositely oriented genes on transposable DNA insertion element IS5. Nature (1982) 2.39
Functional analysis of the replicator structure of lambdoid bacteriophage DNAs. Cold Spring Harb Symp Quant Biol (1979) 2.18
The simian virus 40 T antigen double hexamer assembles around the DNA at the replication origin. J Biol Chem (1992) 1.95
Simian virus 40 large tumor antigen requires three core replication origin domains for DNA unwinding and replication in vitro. Proc Natl Acad Sci U S A (1987) 1.89
Single-stranded-DNA binding alters human replication protein A structure and facilitates interaction with DNA-dependent protein kinase. Mol Cell Biol (1996) 1.83
A bovine papillomavirus type 1-encoded modulator function is dispensable for transient viral replication but is required for establishment of the stable plasmid state. J Virol (1986) 1.74
Human replication protein A binds single-stranded DNA in two distinct complexes. Mol Cell Biol (1994) 1.71
High-resolution analysis of lac transcription complexes inside cells. Biochemistry (1986) 1.51
Strand-specific recognition of a synthetic DNA replication fork by the SV40 large tumor antigen. Science (1992) 1.39
Dimerization of simian virus 40 T-antigen hexamers activates T-antigen DNA helicase activity. J Virol (1997) 1.36
Supercoiling response of the lac ps promoter in vitro. J Mol Biol (1985) 1.35
5' --> 3' molecular polarity of human replication protein A (hRPA) binding to pseudo-origin DNA substrates. Biochemistry (2000) 1.31
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene (2006) 1.29
Strand and face: the topography of interactions between the SV40 origin of replication and T-antigen during the initiation of replication. EMBO J (1994) 1.28
Formation of a complex between nucleolin and replication protein A after cell stress prevents initiation of DNA replication. J Cell Biol (2000) 1.27
The bovine papillomavirus replicon. Ciba Found Symp (1986) 1.22
Amplification of a bovine papillomavirus-simian virus 40 chimera. J Virol (1985) 1.12
Inceptor and origin of DNA replication in lambdoid coliphages. I. The lambda DNA minimal replication system. Gene (1979) 1.11
Synthetic DNA replication bubbles bound and unwound with twofold symmetry by a simian virus 40 T-antigen double hexamer. J Virol (1998) 1.09
Short-wavelength color visual fields in glaucoma suspects at risk. Am J Ophthalmol (1993) 1.08
Two DNA-bound E2 dimers are required for strong transcriptional activation and for cooperation with cellular factors in most cells. New Biol (1991) 1.06
Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector. Gene Ther (2002) 1.04
Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol Lett (1997) 1.04
Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum Gene Ther (2000) 1.00
Short-term effects of levobunolol on ocular pulsatile flow. Am J Ophthalmol (1992) 0.98
Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue. Surv Ophthalmol (1997) 0.96
Denaturation of the simian virus 40 origin of replication mediated by human replication protein A. Mol Cell Biol (1997) 0.93
Unwinding of origin-specific structures by human replication protein A occurs in a two-step process. Nucleic Acids Res (1998) 0.92
A comparison of generalization functions and frame of reference effects in different training paradigms. Percept Psychophys (1992) 0.91
In vitro replication of DNA containing either the SV40 or the polyoma origin. Philos Trans R Soc Lond B Biol Sci (1987) 0.90
Age-related changes in the human lens: a comparison of Scheimpflug photography and lens density index. J Cataract Refract Surg (1994) 0.87
Augmented trabeculectomy in paediatric glaucoma. Br J Ophthalmol (2005) 0.85
Formation of DNA triple helices inhibits DNA unwinding by the SV40 large T-antigen helicase. Nucleic Acids Res (1995) 0.85
Pupillary block following posterior chamber intraocular lens implantation in adults. Br J Ophthalmol (2003) 0.84
Recognition of model DNA replication forks by the SV40 large tumor antigen. Chromosoma (1992) 0.83
Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy. Hum Gene Ther (2001) 0.83
Reproducibility of quantitative anterior chamber angle measurements with scheimpflug video imaging. J Glaucoma (1992) 0.82
Mitomycin C and 5-fluorouracil antimetabolite therapy for pediatric glaucoma filtration surgery. Ophthalmic Surg Lasers (2000) 0.80
Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies. Cancer Gene Ther (2007) 0.80
Differential influence of the E4 adenoviral genes on viral and cellular promoters. J Gene Med (2001) 0.79
Pseudophakic and aphakic pupillary block. Ann Ophthalmol (1988) 0.79
Late visual field changes following cryotherapy for retinopathy of prematurity stage 3. Br J Ophthalmol (1995) 0.78
Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp Eye Res (1988) 0.78
Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death. Endothelium (2001) 0.77
Inceptor and origin of DNA replication in lambdoid coliphages. II. The lambda DNA maximal replication system. Gene (1979) 0.76
The effect of topical beta-adrenoceptor blocking agents on pulsatile ocular blood flow. Eye (Lond) (1995) 0.76
Gene transfer into canine myoblasts. Cytotechnology (1999) 0.75
Distinct roles of two binding sites for the bovine papillomavirus (BPV) E2 transactivator on BPV DNA replication. J Virol (1998) 0.75
The use of fibrin adhesive in trabeculectomy: a pilot study. Br J Ophthalmol (2006) 0.75
Intravitreal gas injection for hypotony after cataract surgery. J Cataract Refract Surg (1998) 0.75
Implantation growth of an iris melanocytic lesion simulating a ciliary body melanoma. Ophthalmic Surg (1987) 0.75
The prevalence of retinal detachment in aphakic high myopic patients. Ophthalmic Surg (1987) 0.75
[Visual disturbances in mitral valve prolapse]. Harefuah (1987) 0.75
Unusual posterior retinal holes associated with high myopia in XYY syndrome. Ann Ophthalmol (1990) 0.75
Threshold sensitivity tests in various ocular diseases. Ann Ophthalmol (1989) 0.75
Detection of replicational inceptor signals in IS5. Cold Spring Harb Symp Quant Biol (1981) 0.75
[Lowering intraocular pressure in glaucoma--by how much?]. Harefuah (1999) 0.75
[Retinal artery obstruction in young patients]. Harefuah (1986) 0.75
A microtest plate assay of functional excitatory amino acid receptors. J Neurosci Methods (1989) 0.75
Ultrasonographic findings of the optic disc in congenital glaucoma. Ophthalmic Surg Lasers (1996) 0.75
Anterior chamber angle configuration before and after iridotomy measured by scheimpflug video imaging. J Glaucoma (1994) 0.75